Similarly, the expression of HIF3A mRNA was significantly diminished in the tumor tissues of 62 LUSC patients (Figure 2A), and HIF3A mRNA expression was significantly lower in plasma samples from 103 LUAD patients and 96 LUSC patients compared with healthy recruits (Figure 3A,B). This evidence concerns the gene HIF3A and neoplasm.